Lactobacillus Rhamnosus GG (ATCC 53103) – Brands in India, Sachet Manufacturer & PCD Franchise (Precam-GG)
Lactobacillus Rhamnosus GG (ATCC 53103) NLT 6 Billion CFU Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Premium-Strain Probiotic
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Lactobacillus Rhamnosus GG (ATCC 53103) NLT 6 Billion CFU Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Lactobacillus Rhamnosus GG (ATCC 53103) NLT 6 Billion CFU Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Lactobacillus Rhamnosus GG (ATCC 53103) NLT 6 Billion CFU Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Lactobacillus Rhamnosus GG (ATCC 53103) NLT 6 Billion CFU formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Lactobacillus Rhamnosus GG – Brands in India for PCD Franchise, Wholesale & Own Brand
Looking for a lactobacillus rhamnosus GG sachet brand or a supplier of LGG (ATCC 53103)? Trumac Healthcare markets the strain as Precam-GG – Lactobacillus rhamnosus GG (ATCC 53103) 10 billion CFU granules, 10 sachets – made at WHO-GMP certified partner units, on a monopoly PCD franchise basis and as wholesale stock across India. LGG is the most studied probiotic strain for acute diarrhoea in children and antibiotic-associated diarrhoea, and paediatricians prescribe it by name.
Precam-GG sits in the paediatric PCD franchise and gastro ranges with Bacillus clausii, Saccharomyces boulardii and multi-strain probiotics. Trumac Healthcare has worked since 2007 and supplies more than 4000 franchise partners; no franchise fee, minimum first order ₹25,000.
Probiotic range
- Precam-GG – Lactobacillus rhamnosus GG (ATCC 53103) 10 billion CFU, 10 sachets
- Bacitic Spores – Bacillus clausii 2 billion spores suspension
- Sactil – Saccharomyces boulardii + lactic acid bacillus
- Dotorac – racecadotril suspension
- Full range: paediatric PCD franchise
Ways to work with us
- PCD pharma franchise – Lactobacillus rhamnosus GG sachets under our brand on a monopoly basis for your area, with visual aids and promotional material
- Wholesale supply – stock for distributors, stockists and hospital suppliers across India, against drug licence and GST
- Own-brand (third-party) enquiries – share the composition, pack and quantity and we will confirm availability and send a quotation
How to start
- Send your requirement on WhatsApp – product, franchise or wholesale, quantity and your area
- Receive the price list and monopoly terms (no franchise fee; minimum first order ₹25,000)
- Confirm the order and pay by NEFT, RTGS or IMPS
- Goods are dispatched once payment reflects, with the docket number for tracking
Questions buyers ask
Which Lactobacillus rhamnosus GG brands are available in India for PCD franchise?
Precam-GG from Trumac Healthcare – LGG (ATCC 53103) 10 billion CFU sachets – made at WHO-GMP certified partner units, on a monopoly PCD franchise basis across India.
Do you supply LGG sachets wholesale?
Yes, to distributors, stockists and hospital suppliers with a valid drug licence. Share quantity and location for the rate.
Is LGG available as a tablet?
Our LGG brand is a 10 billion CFU sachet, the form paediatricians prefer for children; tablet and capsule presentations are available on enquiry.
Can I get Lactobacillus rhamnosus GG under my own brand?
Share your brand name, CFU strength, pack and quantity on WhatsApp and we will confirm availability and send a quotation.
Enquiry: Share your LGG requirement – franchise, wholesale or own brand, with CFU, pack, quantity and location. WhatsApp +91 90416 77932.
Offered by Trumac Healthcare, a PCD pharma franchise company, available on a monopoly basis – see the eye drops pharma franchise product list. Also listed in the sachets, granules and protein powders range. No franchise fee; minimum first order ₹25,000 – cost and documents.
Therapeutic Indications
- Paediatric infective diarrhoea (best evidence)
- Antibiotic-associated diarrhoea
- Atopic dermatitis (prevention in high-risk infants)
- Necrotising enterocolitis prevention
- Helicobacter pylori adjunct
Mechanism of Action
Lactobacillus Rhamnosus GG is the most clinically studied probiotic strain — produces antimicrobial substances, competes with pathogens for receptors, and modulates Th1/Th2 immune balance.
Dosage & Administration
- Children: 1 sachet once or twice daily.
Side Effects
- Mild bloating, flatulence (initial).
- Rare bacteraemia in immunocompromised.
Contraindications
- Severe immunocompromise (relative), central venous catheter in situ, severe pancreatitis (relative).
Storage
Store between 2–25 °C in dry place.
PCD Pharma Franchise for Lactobacillus Rhamnosus GG (ATCC 53103) NLT 6 Billion CFU Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 20 x 1 gm
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Lactobacillus Rhamnosus GG (ATCC 53103) NLT 6 Billion CFU Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Lactobacillus Rhamnosus GG (ATCC 53103) NLT 6 Billion CFU Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Lactobacillus Rhamnosus GG (ATCC 53103) NLT 6 Billion CFU Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Lactobacillus Rhamnosus GG (ATCC 53103) NLT 6 Billion CFU Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Lactobacillus Rhamnosus GG (ATCC 53103) NLT 6 Billion CFU Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Lactobacillus Rhamnosus GG (ATCC 53103) NLT 6 Billion CFU Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Lactobacillus Rhamnosus GG (ATCC 53103) NLT 6 Billion CFU Tablet?
Available pack sizes include: 20 x 1 gm.
What is the MRP / trade price for Lactobacillus Rhamnosus GG (ATCC 53103) NLT 6 Billion CFU Tablet?
MRPs range from ₹1160 to ₹1160 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Lactobacillus Rhamnosus GG (ATCC 53103) NLT 6 Billion CFU Tablet?